- Home
- INHD vs PASG Comparison
INHD vs PASG Comparison
Compare INHD & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- PASG
- Stock Information
- Founded
- INHD 2019
- PASG 2017
- Country
- INHD United States
- PASG United States
- Employees
- INHD N/A
- PASG N/A
- Industry
- INHD
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- INHD
- PASG Health Care
- Exchange
- INHD Nasdaq
- PASG Nasdaq
- Market Cap
- INHD 19.8M
- PASG 20.3M
- IPO Year
- INHD 2023
- PASG 2020
- Fundamental
- Price
- INHD $1.27
- PASG $6.95
- Analyst Decision
- INHD
- PASG Strong Buy
- Analyst Count
- INHD 0
- PASG 4
- Target Price
- INHD N/A
- PASG $59.25
- AVG Volume (30 Days)
- INHD 54.0K
- PASG 82.4K
- Earning Date
- INHD 07-28-2025
- PASG 08-12-2025
- Dividend Yield
- INHD N/A
- PASG N/A
- EPS Growth
- INHD N/A
- PASG N/A
- EPS
- INHD N/A
- PASG N/A
- Revenue
- INHD $2,645,845.00
- PASG N/A
- Revenue This Year
- INHD N/A
- PASG N/A
- Revenue Next Year
- INHD N/A
- PASG N/A
- P/E Ratio
- INHD N/A
- PASG N/A
- Revenue Growth
- INHD 787.64
- PASG N/A
- 52 Week Low
- INHD $1.11
- PASG $5.12
- 52 Week High
- INHD $19.78
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- INHD 43.07
- PASG 53.66
- Support Level
- INHD $1.18
- PASG $5.51
- Resistance Level
- INHD $1.28
- PASG $6.27
- Average True Range (ATR)
- INHD 0.08
- PASG 0.66
- MACD
- INHD 0.02
- PASG 0.19
- Stochastic Oscillator
- INHD 44.61
- PASG 68.76
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.